Zambon, Alberto Andrea
Falzone, Yuri Matteo
Bolino, Alessandra
Previtali, Stefano Carlo https://orcid.org/0000-0003-2546-4357
Article History
Received: 2 January 2024
Revised: 14 March 2024
Accepted: 7 April 2024
First Online: 28 April 2024
Change Date: 26 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00018-024-05305-0
Declarations
:
: Financial interests: Authors AAZ, YMF and AB declare they have no financial interests. Author SCP has received speaker and consultant honoraria from Company Argenx, Alia Therapeutics, LSC Lifescience. Author SCP has served on advisory boards for Company Argenx, Wave Therapeutics, Esperare.
: Not applicable.
: Not applicable.